William M. Miles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
William M. Miles has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Kun Xiang
College of Medicine Department of Medicine Cardiology Division, University of Florida Health, Gainesville, Florida, USA
2 shared publications Philip George
University of Florida College of Medicine, 1329 S.W. 16th Avenue, PO Box 100288, Gainesville, Florida 32608, USA
2 shared publications- Abdullah Omar
Cardiology, University of Florida College of Medicine, Gainesville, USA
1 shared publication - Eldon Matthia
Internal Medicine, University of Florida College of Medicine, Gainesville, USA
1 shared publication - Ellery Altshuler
Department of Internal Medicine, University of Florida, Gainesville, FL 32610, USA
1 shared publication - George J. Arnaoutakis
Institute for Cardiovascular Health , University of Texas at Austin Dell Medical School , Austin , Texas, USA
1 shared publication
Latest Publications
- 15 June 2023
- Published by Elsevier in Cardiology Clinics
- Vol. 41 (3) , 315-332
Physiologic Variants of Cardiac Conduction (Aberration, Gap, Supernormal Conduction)
- 15 June 2023
- Published by Elsevier in Cardiology Clinics
- Vol. 41 (3) , 315-332
Physiologic Variants of Cardiac Conduction (Aberration, Gap, Supernormal Conduction)
- Open Access
- 4 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e21921
Workup for Suspected Brugada Syndrome: Two Case Reports for the General Practitioner
While a large proportion of ST-segment elevation on EKG is related to myocardial ischemia, the differential diagnosis must include pericarditis, channelopathies, and various genetic conditions. Identifying and working up such abnormalities present a challenge to primary care providers (PCPs). We present two clinical cases of young male patients with ST-segment elevation in anteroseptal leads suspicious for Brugada syndrome and show how to risk stratify and manage them. Our first case presents a 23-year-old male with no past medical history with acute onset substernal chest pain, shortness of breath, and palpitations. Initial workup revealed negative serial troponins and normal B-type natriuretic peptide (BNP). The EKG revealed ST elevation in lead V2. An evaluation for Brugada syndrome was pursued. Upon completion of a procainamide challenge, it was determined that he did not have Brugada syndrome and was shortly discharged. Our second case presents a 33-year-old male with no pertinent cardiac medical history who presented to an outpatient cardiology clinic after discovering an incidental ST elevation in V2 on EKG. His family history was negative for early atherosclerotic cardiovascular events or sudden cardiac death. The patient’s initial workup was negative. Suspicion for Brugada syndrome leads to performing a procainamide challenge, which was significant for ST changes in the anterolateral leads. He was asymptomatic during the challenge and initial presentation, and no further intervention was indicated. He was advised to avoid sodium channel blocking medications and treat any fevers and was sent for genetic testing. These cases illustrate the importance of maintaining an appropriate suspicion for Brugada syndrome in young patients with minimal ischemic risk factors. We discuss a guideline-directed algorithmic workup for PCPs in suspicious individuals. Stratifying patients based on the presence of symptoms, history of tachyarrhythmias, and EKG findings before and after drug challenge allows physicians to guide further management of these patients.
- 4 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e21921
Open AccessWorkup for Suspected Brugada Syndrome: Two Case Reports for the General Practitioner
While a large proportion of ST-segment elevation on EKG is related to myocardial ischemia, the differential diagnosis must include pericarditis, channelopathies, and various genetic conditions. Identifying and working up such abnormalities present a challenge to primary care providers (PCPs). We present two clinical cases of young male patients with ST-segment elevation in anteroseptal leads suspicious for Brugada syndrome and show how to risk stratify and manage them. Our first case presents a 23-year-old male with no past medical history with acute onset substernal chest pain, shortness of breath, and palpitations. Initial workup revealed negative serial troponins and normal B-type natriuretic peptide (BNP). The EKG revealed ST elevation in lead V2. An evaluation for Brugada syndrome was pursued. Upon completion of a procainamide challenge, it was determined that he did not have Brugada syndrome and was shortly discharged. Our second case presents a 33-year-old male with no pertinent cardiac medical history who presented to an outpatient cardiology clinic after discovering an incidental ST elevation in V2 on EKG. His family history was negative for early atherosclerotic cardiovascular events or sudden cardiac death. The patient’s initial workup was negative. Suspicion for Brugada syndrome leads to performing a procainamide challenge, which was significant for ST changes in the anterolateral leads. He was asymptomatic during the challenge and initial presentation, and no further intervention was indicated. He was advised to avoid sodium channel blocking medications and treat any fevers and was sent for genetic testing. These cases illustrate the importance of maintaining an appropriate suspicion for Brugada syndrome in young patients with minimal ischemic risk factors. We discuss a guideline-directed algorithmic workup for PCPs in suspicious individuals. Stratifying patients based on the presence of symptoms, history of tachyarrhythmias, and EKG findings before and after drug challenge allows physicians to guide further management of these patients.
- 1 December 2021
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 7 (12) , 1557-1560
Analysis of P-Wave Morphology Is Not Passé in This Era of High-Definition Electroanatomic Mapping
- 1 December 2021
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 7 (12) , 1557-1560
Analysis of P-Wave Morphology Is Not Passé in This Era of High-Definition Electroanatomic Mapping
- 1 December 2021
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 13 (4) , 607-624
Physiologic Variants of Cardiac Conduction (Aberration, Gap, Supernormal Conduction)
- 1 December 2021
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 13 (4) , 607-624
Physiologic Variants of Cardiac Conduction (Aberration, Gap, Supernormal Conduction)
- Open Access
- 30 July 2021
- Published by Springer Nature in Cureus
- Vol. 13 (7)
Massive Tension Hemothorax After Pacemaker Implantation
A case of an 85-year-old male on apixaban and clopidogrel undergoing pacemaker implantation is described. After procedure he developed unilateral tension hemothorax and required emergent drainage and exploratory thoracotomy. No vascular, cardiac, or pulmonary source was identified. After multidisciplinary discussions, it was speculated that spontaneous intercostal vessel rupture due to forceful coughing and elevated blood pressure during the procedure was the most likely cause of bleeding.
- 30 July 2021
- Published by Springer Nature in Cureus
- Vol. 13 (7)
Open AccessMassive Tension Hemothorax After Pacemaker Implantation
A case of an 85-year-old male on apixaban and clopidogrel undergoing pacemaker implantation is described. After procedure he developed unilateral tension hemothorax and required emergent drainage and exploratory thoracotomy. No vascular, cardiac, or pulmonary source was identified. After multidisciplinary discussions, it was speculated that spontaneous intercostal vessel rupture due to forceful coughing and elevated blood pressure during the procedure was the most likely cause of bleeding.
- Open Access
- 1 February 2016
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 1 (2) , 143-155
Principles of Arrhythmia Management During Pregnancy
This paper reviews current recommendations on the appropriate evaluation and management of cardiac arrhythmias in the pregnant patient. Most arrhythmias during pregnancy are benign and require no intervention. When required, the decision to treat should be based on symptom severity and the associated risk to mother and fetus posed by potentially recurring arrhythmia episodes throughout the pregnancy. Any treatment strategy in this patient population has inherent risk to both mother and unborn child. Before the initiation of any intervention, documentation of a clinical arrhythmia and correlation with clinical symptoms should be obtained. There is no role for empiric therapy.
- 1 February 2016
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 1 (2) , 143-155
Open AccessPrinciples of Arrhythmia Management During Pregnancy
This paper reviews current recommendations on the appropriate evaluation and management of cardiac arrhythmias in the pregnant patient. Most arrhythmias during pregnancy are benign and require no intervention. When required, the decision to treat should be based on symptom severity and the associated risk to mother and fetus posed by potentially recurring arrhythmia episodes throughout the pregnancy. Any treatment strategy in this patient population has inherent risk to both mother and unborn child. Before the initiation of any intervention, documentation of a clinical arrhythmia and correlation with clinical symptoms should be obtained. There is no role for empiric therapy.